Thematic Investing

Featured

BUZZ Investing: Ford Surges on EV Push

Blog | November 20

Pharma Sector Steps up as a Portfolio Prescription

Explore All

Related Funds

EVX
VanEck Environmental Services ETF

BJK
VanEck Gaming ETF

BBH
VanEck Biotech ETF

RTH
VanEck Retail ETF

SMH
VanEck Semiconductor ETF

PPH
VanEck Pharmaceutical ETF

Fund Description

VanEck Pharmaceutical ETF (PPH^®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS^®US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Fund Ticker
PPH
Exchange
NASDAQ
ETF Structure
Physical
Administrator
Van Eck Associates
Custodian
State Street Bank and Trust Company
Index Ticker
MVPPHTR
Index Rebalancing
Quarterly

as of 01/25/22

30-Day SEC Yield
1.70%
Total Net Assets
$381.0M
Number of Holdings
25
Options
Available
Gross Expense Ratio²
0.35%
Net Expense Ratio/TER²
0.35%
Distribution Frequency
Quarterly

Schedule a Call

Key Points

Highly Liquid Companies
Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

Industry Leaders
Index methodology favors the largest companies in the industry

Global Scope
Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

Fund Ticker
PPH
Index Total Return Ticker
MVPPHTR
NAV
PPHNV
Intraday NAV (IIV)⁴
PPHIV
Shares Outstanding
5,138,138
Estimated Cash
PPHEU
Total Cash
PPHTC
CUSIP
92189F692
ISIN
US92189F6925

Source: Bloomberg

Fees and Expenses²

Management Fee
0.35%
Other Expenses
--
Acquired Fund Fees and Expenses
--
Gross Expense Ratio
0.35%
Fee Waivers and
Expense Reimbursement
--
Net Expense Ratio/TER²
0.35%

²Van Eck Associates Corporation (the “Adviser”) will pay all expenses of the Fund, except for the fee payment under the investment management agreement, acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses.

Investment Professionals

Peter Liao, CFA

Portfolio Manager and Head of Equity ETFs
Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
Joined VanEck in 2005
CFA charterholder; member of the CFA Society New York
BA, Mathematics and Economics, New York University

Guo Hua (Jason) Jin

Portfolio Manager and Analyst for Equity ETFs
Joined VanEck in 2007
Prior to his current role, held a portfolio administration position at VanEck
Previously, Portfolio Analyst at Evaluation Associates
BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo

Griffin Driscoll

Analyst for Equity ETFs
Joined VanEck in 2018
Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
BS, Finance, Providence College

Ralph Lasta

Analyst for Equity ETFs
Joined VanEck in 2019
Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
BS, Accounting, Hunter College

Prices as of 01/25/22

	NAV/ Market Price	Volume 30-Day Avg./ Last Trading Day	Daily Change NAV/ Last Price	YTD Change NAV/ Last Price	Premium/ Discount	Prem/Discount Distribution Charts	NAV & Prem/Discount History	30-Day Median Bid Ask Spread	NAV Chart
PPH	$74.16 $74.17	60,760 132,661	$0.07 / +0.10% $0.13 / +0.18%	-3.63% -3.63%	$0.01 0.02%			0.04%

Premium/Discount History as of 01/25/22

		Calendar Year 2020	1Q 2021	2Q 2021	3Q 2021	4Q 2021
	Days closed at a premium	124	32	37	36	41
PPH	Days closed at NAV	17	6	5	5	8
	Days closed at a discount	112	23	21	23	15

Performance History: Average Annual Total Returns* (%)
View All ETFs View All Indices

Monthly Returns

Month End as of 12/31/21
Quarter End as of 12/31/21

	1 MO	3 MO	YTD	1 YR	3 YR	5 YR	10 YR	LIFE 12/20/11
PPH (NAV)	8.07	6.75	18.30	18.30	14.03	10.05	10.04	10.13
PPH (Share Price)	8.12	6.56	18.27	18.27	14.19	10.04	10.04	10.24
MVPPHTR (Index)	8.00	6.65	17.48	17.48	13.56	9.81	9.93	10.02
Performance Differential (NAV - Index)	0.07	0.10	0.82	0.82	0.47	0.24	0.11	0.11

	1 MO	3 MO	YTD	1 YR	3 YR	5 YR	10 YR	LIFE 12/20/11
PPH (NAV)	8.07	6.75	18.30	18.30	14.03	10.05	10.04	10.13
PPH (Share Price)	8.12	6.56	18.27	18.27	14.19	10.04	10.04	10.24
MVPPHTR (Index)	8.00	6.65	17.48	17.48	13.56	9.81	9.93	10.02
Performance Differential (NAV - Index)	0.07	0.10	0.82	0.82	0.47	0.24	0.11	0.11

*Returns less than one year are not annualized.

The table presents past performance which is no guarantee of future results and which may be lower or higher than current performance. Returns reflect temporary contractual fee waivers and/or expense reimbursements. Had the ETF incurred all expenses and fees, investment returns would have been reduced. Investment returns and ETF share values will fluctuate so that investors' shares, when redeemed, may be worth more or less than their original cost. ETF returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.

The "Net Asset Value" (NAV) of a VanEck Exchange Traded Fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. VanEck ETF investors should not expect to buy or sell shares at NAV.

Top 10 Holdings (%) as of 12/31/21 Daily Holdings

Total Holdings: 25

Swipe
to view
full data

Holding Name	Ticker	Shares	Market Value (US$)	% of Net Assets
Pfizer Inc	PFE US	340,972	20,134,397	5.46
Eli Lilly And Co	LLY US	71,733	19,814,089	5.38
Abbvie Inc	ABBV US	143,812	19,472,145	5.28
Bristol-Myers Squibb Co	BMY US	304,273	18,971,422	5.15
Novartis Ag	NVS US	215,411	18,842,000	5.11
Astrazeneca Plc	AZN US	317,903	18,517,850	5.03
Merck & Co Inc	MRK US	239,393	18,347,080	4.98
Sanofi	SNY US	365,203	18,296,670	4.97
Johnson & Johnson	JNJ US	106,644	18,243,589	4.95
Amerisourcebergen Corp	ABC US	130,523	17,345,201	4.71
Top 10 Total (%)				51.02

These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 12/31/21

Country
% of Net Assets
■
United States
67.88
■
United Kingdom
9.45
■
Switzerland
5.11
■
France
4.97
■
Denmark
4.70
■
Japan
4.23
■
Israel
3.36
■
Ireland
0.54
■
Other/Cash
-0.23

Sector Weightings (%) as of 12/31/21

Sector
% of Net Assets
■
Health Care
97.5
■
n/a
2.7
■
Other/Cash
-0.2